Ofelia Olivero
Ofelia Olivero is a renowned biologist and research scientist known for her significant contributions to the field of molecular biology. She is currently serving as the Chief of the Intramural Diversity Workforce Branch at the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH).
Early Life and Education[edit | edit source]
Olivero was born and raised in Argentina. She completed her undergraduate studies in biology at the University of Buenos Aires. She then pursued her doctoral studies in molecular genetics at the same university.
Career[edit | edit source]
Olivero began her career at the National Cancer Institute in 1987. She initially worked as a visiting fellow in the Laboratory of Experimental Carcinogenesis. Her research primarily focused on the molecular mechanisms of carcinogenesis, particularly the role of DNA damage and repair in the process.
In 1992, Olivero was promoted to the position of Staff Scientist. She continued her research on carcinogenesis, and her work led to significant advancements in understanding the molecular mechanisms of chemotherapy drugs.
In 2010, Olivero was appointed as the Chief of the Intramural Diversity Workforce Branch at the NCI. In this role, she is responsible for promoting diversity and inclusion in the scientific workforce.
Research[edit | edit source]
Olivero's research has significantly contributed to the understanding of the molecular mechanisms of carcinogenesis. Her work has particularly focused on the role of DNA damage and repair in the process. She has also conducted extensive research on the molecular mechanisms of chemotherapy drugs, which has led to advancements in cancer treatment.
Awards and Recognition[edit | edit source]
Olivero has received numerous awards and recognition for her contributions to the field of molecular biology. These include the NIH Director's Award and the NCI Women Scientist Advisors' Mentoring and Leadership Award.
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD